Expanded Access Protocol of Troriluzole in Patients With Spinocerebellar Ataxia (SCA)
- Conditions
- First Posted Date
- 2023-09-13
- Last Posted Date
- 2024-11-05
- Lead Sponsor
- Biohaven Pharmaceuticals, Inc.
- Registration Number
- NCT06034886
A Study to Evaluate the Efficacy and Safety of Taldefgrobep Alfa in Participants With Spinal Muscular Atrophy
- Conditions
- Interventions
- First Posted Date
- 2022-04-20
- Last Posted Date
- 2023-11-07
- Lead Sponsor
- Biohaven Pharmaceuticals, Inc.
- Target Recruit Count
- 269
- Registration Number
- NCT05337553
- Locations
- 🇺🇸
CHOP Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
🇨🇿Motol University Hospital, Prague, Czechia
🇪🇸Maternal-Child'S Hospital of Málaga, Regional University Hospital - Pediatric Neurology Unit, Málaga, Spain
Expanded Access Protocol of Verdiperstat in Patients With Multiple System Atrophy (MSA)
- Conditions
- First Posted Date
- 2021-10-20
- Last Posted Date
- 2022-10-06
- Lead Sponsor
- Biohaven Pharmaceuticals, Inc.
- Registration Number
- NCT05086094
- Locations
- 🇺🇸
PPD, Morrisville, North Carolina, United States
Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder
- First Posted Date
- 2021-01-14
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- Biohaven Pharmaceuticals, Inc.
- Target Recruit Count
- 1200
- Registration Number
- NCT04708834
- Locations
- 🇺🇸
CalNeuro Research Group, Los Angeles, California, United States
🇺🇸Clarity Clinical Research, Los Angeles, California, United States
🇺🇸University of Chicago Department of Psychiatry & Behavioral Neuroscience, Chicago, Illinois, United States
Efficacy and Safety Study of Adjunctive Troriluzule in Obsessive Compulsive Disorder
- First Posted Date
- 2021-01-05
- Last Posted Date
- 2024-04-19
- Lead Sponsor
- Biohaven Pharmaceuticals, Inc.
- Target Recruit Count
- 700
- Registration Number
- NCT04693351
- Locations
- 🇺🇸
Om Research LLC, Lancaster, California, United States
🇺🇸CI Trials, Riverside, California, United States
🇺🇸Clintex Research, Miami, Florida, United States
Efficacy and Safety Study of Adjunctive Troriluzole in Obsessive Compulsive Disorder
- First Posted Date
- 2020-11-23
- Last Posted Date
- 2024-04-19
- Lead Sponsor
- Biohaven Pharmaceuticals, Inc.
- Target Recruit Count
- 700
- Registration Number
- NCT04641143
- Locations
- 🇺🇸
Global Clinical Trials, Costa Mesa, California, United States
🇺🇸Hassman Research Institute, Berlin, New Jersey, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
Autologous Memory-like NK Cell Therapy With BHV-1100 and Low Dose IL-2 in Multiple Myeloma Patients
- Conditions
- Interventions
- First Posted Date
- 2020-11-18
- Last Posted Date
- 2024-10-11
- Lead Sponsor
- Biohaven Pharmaceuticals, Inc.
- Target Recruit Count
- 25
- Registration Number
- NCT04634435
- Locations
- 🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States
Study of BHV-3241 in Participants With Multiple System Atrophy
- First Posted Date
- 2019-05-16
- Last Posted Date
- 2023-09-29
- Lead Sponsor
- Biohaven Pharmaceuticals, Inc.
- Target Recruit Count
- 421
- Registration Number
- NCT03952806
- Locations
- 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Randomized Trial of Adult Participants With Generalized Anxiety Disorder
- First Posted Date
- 2019-02-04
- Last Posted Date
- 2024-05-08
- Lead Sponsor
- Biohaven Pharmaceuticals, Inc.
- Target Recruit Count
- 881
- Registration Number
- NCT03829241
- Locations
- 🇺🇸
CalNeuro Research Group, Los Angeles, California, United States
🇺🇸University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸Boston Clinical Trials, Boston, Massachusetts, United States
Troriluzole in Adult Subjects With Spinocerebellar Ataxia
- Conditions
- Interventions
- First Posted Date
- 2018-10-10
- Last Posted Date
- 2024-01-25
- Lead Sponsor
- Biohaven Pharmaceuticals, Inc.
- Target Recruit Count
- 218
- Registration Number
- NCT03701399
- Locations
- 🇺🇸
University of South Florida, Tampa, Florida, United States
🇺🇸UCLA, Los Angeles, California, United States
🇺🇸University of Pennsylvania, Philadelphia, Pennsylvania, United States